| 000 | 01167 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250518010249.0 | ||
| 264 | 0 | _c20200102 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1531-8257 | ||
| 024 | 7 |
_a10.1002/mds.27535 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFischer, D Luke | |
| 245 | 0 | 0 |
_aBDNF provides many routes toward STN DBS-mediated disease modification. _h[electronic resource] |
| 260 |
_bMovement disorders : official journal of the Movement Disorder Society _c01 2019 |
||
| 300 |
_a22-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xpharmacology |
| 650 | 0 | 4 | _aDeep Brain Stimulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeuroprotective Agents |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aSubthalamic Nucleus _xmetabolism |
| 700 | 1 | _aSortwell, Caryl E | |
| 773 | 0 |
_tMovement disorders : official journal of the Movement Disorder Society _gvol. 34 _gno. 1 _gp. 22-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/mds.27535 _zAvailable from publisher's website |
| 999 |
_c29055334 _d29055334 |
||